Michelle Turner

1.7k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Michelle Turner is a scholar working on Physiology, Clinical Biochemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michelle Turner has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Clinical Biochemistry and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michelle Turner's work include Pain Mechanisms and Treatments (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotic Use and Resistance (3 papers). Michelle Turner is often cited by papers focused on Pain Mechanisms and Treatments (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotic Use and Resistance (3 papers). Michelle Turner collaborates with scholars based in United States, Netherlands and Canada. Michelle Turner's co-authors include Leif Saager, Beth Burnside, Michael S. Avidan, Alex S. Evers, Michael M. Bottros, Srikar Rao, Eric Jacobsohn, Lini Zhang, Charles B. Hantler and Kevin J. Finkel and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and Brain Research.

In The Last Decade

Michelle Turner

21 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anesthesia Awareness and the Bispectral Index

2008 499 citations Michael S. Avidan, Lini Zhang et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Michelle Turner

Since Specialization

Citations

This map shows the geographic impact of Michelle Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Turner more than expected).

Fields of papers citing papers by Michelle Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Turner. The network helps show where Michelle Turner may publish in the future.

Co-authorship network of co-authors of Michelle Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Turner. A scholar is included among the top collaborators of Michelle Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Turner. Michelle Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rethinking residency recruitment, application, and interview processes to benefit applicants and programs long-term 2022 ·Journal of the American Pharmacists Association ·(unknown), (unknown), Jamie L. Wagner, Katie E. Barber, P. Brandon Bookstaver, Bruce M Jones, Christopher M. Bland, (unknown), (unknown), (unknown), (unknown), Michelle Turner, (unknown), Kayla R. Stover	1
2	A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in Non–Hospital Care Settings in 2021 2022 ·Open Forum Infectious Diseases ·(unknown), (unknown), Elias B. Chahine, (unknown), (unknown), Katie E. Barber, (unknown), (unknown), Spencer H. Durham, (unknown), (unknown), (unknown), Michelle Turner, (unknown), P. Brandon Bookstaver, Christopher M. Bland	1
3	Evaluation of pharmacy residency recruitment and interview processes during the COVID‐19 pandemic (2020‐2021 application cycle) 2022 ·JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY ·(unknown), (unknown), Jamie L. Wagner, Katie E. Barber, P. Brandon Bookstaver, (unknown), (unknown), Christopher M. Bland, Bruce M Jones, (unknown), (unknown), Michelle Turner, (unknown), Kayla R. Stover	2
4	A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2019 2020 ·Open Forum Infectious Diseases ·Kayla R. Stover, Elias B. Chahine, David B. Cluck, (unknown), Daniel B. Chastain, (unknown), (unknown), Katherine Lusardi, (unknown), Michelle Turner, P. Brandon Bookstaver, Christopher M. Bland	3
5	Motivations and Barriers Associated With Physician Volunteerism for an International Telemedicine Organization 2019 ·Frontiers in Public Health ·Erin Kim, Stephen B. Fox, (unknown), Michelle Turner, Timothy D. Girard, Stephen Y. Chan	9
6	Physician Experience with Direct-To-Consumer Genetic Testing in Kaiser Permanente 2019 ·Journal of Personalized Medicine ·(unknown), Pim Suwannarat, Andrea N. Burnett‐Hartman, Nikki M. Carroll, Michelle Turner, (unknown), (unknown), (unknown), Nazneen Aziz, Elizabeth A. McGlynn	16
7	A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2017 2019 ·Open Forum Infectious Diseases ·Daniel B. Chastain, David B. Cluck, Kayla R. Stover, Katherine Lusardi, (unknown), (unknown), (unknown), Michelle Turner, Elias B. Chahine, P. Brandon Bookstaver, Christopher M. Bland	7
8	Evaluation of an Evidence-Based Medicine Curriculum in a PGY1 Pharmacy Residency Program Using the Fresno Test 2018 ·American Journal of Pharmaceutical Education ·Julie Cooper, Michelle Turner, (unknown), (unknown), (unknown), (unknown), (unknown)	4
9	Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections 2017 ·Infectious Diseases and Therapy ·(unknown), Michelle Turner, (unknown), Cynthia B. Snider, Jordan R. Smith	49
10	Origin of pre-Columbian guinea pigs from Caribbean archeological sites revealed through genetic analysis 2016 ·Journal of Archaeological Science Reports ·Birgitta Kimura, Michelle J. LeFebvre, Susan D. deFrance, (unknown), Michelle Turner, (unknown), Scott M. Fitzpatrick, Connie J. Mulligan	22
11	Anesthesia Awareness and the Bispectral Index breakdown → 2008 ·New England Journal of Medicine ·Michael S. Avidan, Lini Zhang, Beth Burnside, Kevin J. Finkel, Adam C. Searleman, (unknown), Leif Saager, Michelle Turner, Srikar Rao, Michael M. Bottros, Charles B. Hantler, Eric Jacobsohn, Alex S. Evers	499
12	Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks 2007 ·Journal of Internal Medicine ·Michelle Turner, D. B. May, (unknown), (unknown)	49
13	Emerging echinocandins for treatment of invasive fungal infections 2006 ·Expert Opinion on Emerging Drugs ·Michelle Turner, Richard H. Drew, John R. Perfect	36
14	SYM 2081, an agonist that desensitizes kainate receptors, attenuates capsaicin and inflammatory hyperalgesia 2003 ·Brain Research ·Michelle Turner, Darryl T. Hamamoto, James S. Hodges, Maria L. Maccecchini, Donald A. Simone	10
15	Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain 2002 ·Journal of the Peripheral Nervous System ·(unknown), (unknown), Michelle Turner, Gwen Wendelschafer‐Crabb, (unknown), (unknown), (unknown)	2
16	Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms 2001 ·Pain ·Lisa M. Johanek, (unknown), Michelle Turner, Nader D. Nader, Jim Hodges, Donald A. Simone	75
17	Vasopressin receptor mutations causing nephrogenic diabetes insipidus. 1999 ·PubMed ·Daniel G. Bichet, Michelle Turner, Didier Morin	19
18	Potential impact of climate change effects on preferences for tourism destinations. A psychological pilot study 1999 ·Climate Research ·(unknown), Martin Lohmann, (unknown), Michèle Meyer, (unknown), (unknown), A Riedel, Michelle Turner	52
19	Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus 1998 ·Journal of the American Society of Nephrology ·Yahya S. Al‐Awthan, Didier Morin, Bernard Mouillac, Nancy Sabatier, (unknown), Nathalie de la Cotte, M Déchaux, Corinne Antignac, Marie‐Françoise Arthus, Michèle Lonergan, Michelle Turner, M N Balestre, G. Alonso, Marcel Hibert, Claude Barberis, Geoffrey N. Hendy, Daniel G. Bichet, Serge Jard	80
20	Dopamine receptor modulation of corticosterone secretion in neonatal and adult rats 1988 ·Journal of Pharmacy and Pharmacology ·Ian Kitchen, (unknown), Michelle Turner	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact